Abstract
Research suggests that statins could be useful to treat vascular manifestations related to systemic sclerosis, but data on their potential clinical benefits remain limited. Previous studies suggested that statins increase the number of circulating endothelial precursor cells, and thereby improve the severity of Raynaud's phenomenon. Abou-Raya et al. have published the first randomized, double-blind, placebo-controlled clinical trial on the effect of statins on clinical outcomes in the vascular manifestations of systemic sclerosis. They observed significant reductions in the overall number of digital ulcers and in the mean number of new digital ulcers per patient in the statin group. In addition, statin-treated patients experienced significant improvements in disability scores and functional status. The data from this study indicate that statins might improve endothelial function, thereby contributing to clinical, functional recovery. These results pave the way for large studies on the use of statins in vascular complications related to systemic sclerosis.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Derk CT and Jimenez SA (2006) Statins and the vasculopathy of systemic sclerosis: potential therapeutic agents? Autoimmun Rev 5: 25–32
Gomez-Cerezo JF et al. (2007) The role of endothelial progenitor cells and statins in endothelial function: a review. Cardiovasc Hematol Agents Med Chem 5: 265–272
Distler JH et al. (2008) EUSTAR statement and recommendations on endothelial precursor cells. Ann Rheum Dis, in press
Kuwana M et al. (2006) Increase in circulating endothelial precursors by atorvastatin in patients with systemic sclerosis. Arthritis Rheum 53: 1946–1951
Del Papa N et al. (2008) Simvastatin reduces endothelial activation and damage but is partially ineffective in inducing endothelial repair in systemic sclerosis. J Rheumatol 35: 1323–1328
Abou-Raya et al. (2008) Statins: potentially useful therapy of systemic sclerosis-related Raynaud's phenomenon and digital ulcers. J Rheumatol 35: 1801–1808
Medsger TA Jr et al. (1999) A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 26: 2159–2167
Wiviot SD and Cannon CP (2006) The safety and efficacy of achieving very low LDL-cholesterol concentrations with high dose statin therapy. Curr Opin Lipidol 17: 626–630
Kao PN (2005) Simvastatin treatment of pulmonary hypertension: an observational case series. Chest 127: 1446–1452
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Blagojevic, J., Matucci-Cerinic, M. Are statins useful for treating vascular involvement in systemic sclerosis?. Nat Rev Rheumatol 5, 70–71 (2009). https://doi.org/10.1038/ncprheum0993
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncprheum0993
This article is cited by
-
Targeted therapy for systemic sclerosis: how close are we?
Nature Reviews Rheumatology (2010)